All-trans retinoic acid (ATRA)
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for All-trans retinoic acid (ATRA), covering 2006-11-17 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma [Phase 2]